MoverLensOpen Dashboard
Public X Voice · tracked by MoverLens
PharmD_KS avatar

PharmD_KS

@pharmd_ks · 24.2K followers on X · public trading commentary, structured and backtested

MoverLens turns PharmD_KS's public stock posts into a researchable track record: each call is extracted by AI with ticker, direction and confidence, then measured against what the market actually did.

Documented calls
78
latest 2026-08-26
Hit rate · 7d
57%
53 scored calls
Stocks covered
32
Bullish lean
79%
62 bull · 16 bear
Signal cadence
2/week
last 90 days
Tracked since
2023-10

Trading style

@pharmd_ks covers 30 tickers spanning other and nearby sectors, posting 39 signals over ninety days to about 24K followers. The account leans primarily bullish, with roughly 56% of its 48 scored calls moving in the called direction over a seven-day horizon. Its strongest documented call was a bullish OKLO position that gained 72%.

Strongest documented call

A bullish call on OKLO that moved +73.0% in the called direction over the measured horizon. Every call on the full record links back to its original public post.

Most-discussed stocks

NOW · 8NQ · 7ES · 6DIS · 6OKLO · 5SPX · 4

See every call @pharmd_ks has made

Start a 7-day Signal Pro trial to explore the full record — every documented call with its original post, confidence, and outcome.

Open the full recordBrowse the Leaderboard →

Similar tracked Voices

Questions about this record

What is PharmD_KS's hit rate on stock calls?

Across 53 scored calls tracked by MoverLens, roughly 57% moved in the called direction over a 7-day horizon. Hit rate alone does not capture the size of moves — open the full record for the complete methodology.

What stocks does @pharmd_ks post about most?

The most frequent tickers in this account's documented calls are NOW, NQ, ES, DIS, out of 32 stocks covered.

How does MoverLens track @pharmd_ks?

MoverLens monitors this account's public X posts, uses AI to extract ticker-level calls with direction and confidence, and backtests each call against market data using a versioned methodology. It is research, not investment advice.

MoverLens structures public market commentary for research. Nothing on this page is investment advice or a recommendation to trade; AI extraction and market data can be incomplete or wrong, and past performance does not predict future results. Public posts only.  ·  Terms · Privacy · Disclaimer · info@moverlens.com